SCHEMBL26022388

SCHEMBL26022388

CCC(=O)NC(C)[C@@H](C)CC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.46
ALDH1A1 P00352 1/20 0.39
MME P08473 2/20 0.38
ACE P12821 2/20 0.38
CPA1 P15085 2/20 0.38
ACE2 Q9BYF1 2/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MMP1 P03956 2/20 0.34
MMP2 P08253 2/20 0.34
MMP3 P08254 1/20 0.34
PSMB5 P28074 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
FAAH O00519 1/20 0.33
MAPK1 P28482 1/20 0.33
TSHR P16473 1/20 0.33
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
PKM P14618 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13975597 1.00 CYP2C9 (0.46) CYP2C9ALDH1A1MMEACECPA1
SCHEMBL8433765 0.82 ALDH1A1 (0.37) CYP2C9ALDH1A1MMEACECPA1
SCHEMBL15116382 0.82 GAA (0.40) ALDH1A1MMEACECPA1ACE2
SCHEMBL13036378 0.80 CYP2C9 (0.50) CYP2C9ALDH1A1MEN1KMT2APSMB5
SCHEMBL12295563 0.80 CYP2C9 (0.50) CYP2C9ALDH1A1MEN1KMT2APSMB5
SCHEMBL8402243 0.80 CYP2C9 (0.50) CYP2C9ALDH1A1MEN1KMT2APSMB5
SCHEMBL22304296 0.78 CYP2C9 (0.48) CYP2C9ALDH1A1MEN1KMT2AMMP1
SCHEMBL6729268 0.78 ALDH1A1 (0.41) ALDH1A1MMEACECPA1ACE2
SCHEMBL8145207 0.78 TRPV1 (0.42) ALDH1A1MMEACECPA1ACE2
SCHEMBL8134506 0.78 TRPV1 (0.42) ALDH1A1MMEACECPA1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed